Tag Archives: drug benefits

Dr. Vogenberg on Regulatory and Legislative Changes Effect on Healthcare, P&T Committees

AMI founding partner Dr. Randy Vogenberg recently co-authored an article for Pharmacy & Therapeutics (P&T)’s January 2018 issue entitled “Regulatory Change Versus Legislation Impacting Health Care Decisions and Delivery”.  The article explores high-level trends of the Trump administration’s policy, legislative agenda, and regulations, focusing on FDA policies that may affect drug prices and relaxation of the […]